Radiation oncology as a profession is in a period of retrenchment due to the economic crisis. There is also a growing demand from payors to show value for these treatments, said ASTRO President Anthony Zeitman, M.D. He says the technologies used need to undergo rigorous clinical testing to show what works best and what is most cost-effective. Part of ASTRO's push is for a national registry to help advance this data collection.
Related Content
News
Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...
August 09, 2024 
News | Radiology Business
July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...
July 31, 2024 
News | PET-CT
July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...
July 31, 2024 
Feature | Radiation Oncology | By Christine Book
News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...
July 30, 2024 
July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...
July 24, 2024 
News | Radiation Therapy
July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...
July 22, 2024 
News | ASTRO
July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...
July 18, 2024 
News | PET-CT
July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...
July 16, 2024 
News | Digital Pathology
July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...
July 12, 2024 
News | Digital Pathology
July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...
July 12, 2024 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now